Cargando…
Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333997/ https://www.ncbi.nlm.nih.gov/pubmed/35908561 http://dx.doi.org/10.1016/S0140-6736(22)01295-8 |
| _version_ | 1784759003074527232 |
|---|---|
| author | Mehta, Puja Titanji, Boghuma K |
| author_facet | Mehta, Puja Titanji, Boghuma K |
| author_sort | Mehta, Puja |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9333997 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93339972022-07-29 Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality Mehta, Puja Titanji, Boghuma K Lancet Comment Elsevier Ltd. 2022 2022-07-28 /pmc/articles/PMC9333997/ /pubmed/35908561 http://dx.doi.org/10.1016/S0140-6736(22)01295-8 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Mehta, Puja Titanji, Boghuma K Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality |
| title | Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality |
| title_full | Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality |
| title_fullStr | Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality |
| title_full_unstemmed | Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality |
| title_short | Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality |
| title_sort | baricitinib in covid-19: a coming-of-age from artificial intelligence to reducing mortality |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333997/ https://www.ncbi.nlm.nih.gov/pubmed/35908561 http://dx.doi.org/10.1016/S0140-6736(22)01295-8 |
| work_keys_str_mv | AT mehtapuja baricitinibincovid19acomingofagefromartificialintelligencetoreducingmortality AT titanjiboghumak baricitinibincovid19acomingofagefromartificialintelligencetoreducingmortality |